US Stock MarketDetailed Quotes

ALDX Aldeyra Therapeutics

Watchlist
  • 5.100
  • +0.910+21.72%
Close Aug 9 16:00 ET
  • 4.990
  • -0.110-2.16%
Post 20:01 ET
303.05MMarket Cap-7968P/E (TTM)

Aldeyra Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
74.11%18.01M
-44.10%9.39M
-31.73%42.79M
-55.48%6.1M
-35.40%9.55M
-41.62%10.34M
1.94%16.8M
11.49%62.68M
-11.08%13.7M
-4.25%14.78M
Selling and administrative expenses
-10.11%3.04M
-42.34%3.21M
-13.26%13.34M
-62.00%1.8M
-20.22%2.59M
7.49%3.38M
31.02%5.57M
36.26%15.37M
84.77%4.74M
27.41%3.24M
-General and administrative expense
-10.11%3.04M
-42.34%3.21M
-13.26%13.34M
-62.00%1.8M
-20.22%2.59M
7.49%3.38M
31.02%5.57M
36.26%15.37M
84.77%4.74M
27.41%3.24M
Research and development costs
114.99%14.97M
-44.97%6.18M
-37.73%29.46M
-52.04%4.3M
-39.67%6.96M
-52.21%6.96M
-8.16%11.24M
5.27%47.31M
-30.21%8.96M
-10.51%11.54M
Operating profit
-74.11%-18.01M
44.10%-9.39M
31.73%-42.79M
55.48%-6.1M
35.40%-9.55M
41.62%-10.34M
-1.94%-16.8M
-11.49%-62.68M
11.08%-13.7M
4.25%-14.78M
Net non-operating interest income expense
-14.42%1.16M
10.45%1.31M
701.34%5.25M
69.24%1.34M
489.43%1.36M
2,153.50%1.36M
489.91%1.19M
142.10%655.35K
326.84%794.63K
165.38%231.33K
Non-operating interest income
-13.01%1.64M
7.83%1.81M
211.69%7.32M
48.08%1.86M
193.45%1.9M
446.72%1.88M
1,556.00%1.68M
1,167.49%2.35M
1,904.52%1.26M
993.05%648.24K
Non-operating interest expense
-9.40%477.6K
1.47%498.53K
22.27%2.07M
11.60%514.26K
29.22%538.74K
28.45%527.14K
21.02%491.29K
-2.76%1.69M
11.60%460.82K
0.92%416.92K
Other net income (expense)
Income before tax
-87.47%-16.85M
48.24%-8.08M
39.47%-37.54M
63.16%-4.75M
43.75%-8.19M
49.46%-8.99M
6.98%-15.62M
-7.35%-62.02M
18.11%-12.9M
7.86%-14.55M
Income tax
Net income
-87.47%-16.85M
48.24%-8.08M
39.47%-37.54M
63.16%-4.75M
43.75%-8.19M
49.46%-8.99M
6.98%-15.62M
-7.35%-62.02M
18.11%-12.9M
7.86%-14.55M
Net income continuous Operations
-87.47%-16.85M
48.24%-8.08M
39.47%-37.54M
63.16%-4.75M
43.75%-8.19M
49.46%-8.99M
6.98%-15.62M
-7.35%-62.02M
18.11%-12.9M
7.86%-14.55M
Minority interest income
Net income attributable to the parent company
-87.47%-16.85M
48.24%-8.08M
39.47%-37.54M
63.16%-4.75M
43.75%-8.19M
49.46%-8.99M
6.98%-15.62M
-7.35%-62.02M
18.11%-12.9M
7.86%-14.55M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-87.47%-16.85M
48.24%-8.08M
39.47%-37.54M
63.16%-4.75M
43.75%-8.19M
49.46%-8.99M
6.98%-15.62M
-7.35%-62.02M
18.11%-12.9M
7.86%-14.55M
Basic earnings per share
-86.67%-0.28
48.15%-0.14
39.62%-0.64
63.64%-0.08
44.00%-0.14
50.00%-0.15
6.90%-0.27
0.93%-1.06
18.52%-0.22
7.41%-0.25
Diluted earnings per share
-86.67%-0.28
48.15%-0.14
39.62%-0.64
63.64%-0.08
44.00%-0.14
50.00%-0.15
6.90%-0.27
0.93%-1.06
18.52%-0.22
7.41%-0.25
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 74.11%18.01M-44.10%9.39M-31.73%42.79M-55.48%6.1M-35.40%9.55M-41.62%10.34M1.94%16.8M11.49%62.68M-11.08%13.7M-4.25%14.78M
Selling and administrative expenses -10.11%3.04M-42.34%3.21M-13.26%13.34M-62.00%1.8M-20.22%2.59M7.49%3.38M31.02%5.57M36.26%15.37M84.77%4.74M27.41%3.24M
-General and administrative expense -10.11%3.04M-42.34%3.21M-13.26%13.34M-62.00%1.8M-20.22%2.59M7.49%3.38M31.02%5.57M36.26%15.37M84.77%4.74M27.41%3.24M
Research and development costs 114.99%14.97M-44.97%6.18M-37.73%29.46M-52.04%4.3M-39.67%6.96M-52.21%6.96M-8.16%11.24M5.27%47.31M-30.21%8.96M-10.51%11.54M
Operating profit -74.11%-18.01M44.10%-9.39M31.73%-42.79M55.48%-6.1M35.40%-9.55M41.62%-10.34M-1.94%-16.8M-11.49%-62.68M11.08%-13.7M4.25%-14.78M
Net non-operating interest income expense -14.42%1.16M10.45%1.31M701.34%5.25M69.24%1.34M489.43%1.36M2,153.50%1.36M489.91%1.19M142.10%655.35K326.84%794.63K165.38%231.33K
Non-operating interest income -13.01%1.64M7.83%1.81M211.69%7.32M48.08%1.86M193.45%1.9M446.72%1.88M1,556.00%1.68M1,167.49%2.35M1,904.52%1.26M993.05%648.24K
Non-operating interest expense -9.40%477.6K1.47%498.53K22.27%2.07M11.60%514.26K29.22%538.74K28.45%527.14K21.02%491.29K-2.76%1.69M11.60%460.82K0.92%416.92K
Other net income (expense)
Income before tax -87.47%-16.85M48.24%-8.08M39.47%-37.54M63.16%-4.75M43.75%-8.19M49.46%-8.99M6.98%-15.62M-7.35%-62.02M18.11%-12.9M7.86%-14.55M
Income tax
Net income -87.47%-16.85M48.24%-8.08M39.47%-37.54M63.16%-4.75M43.75%-8.19M49.46%-8.99M6.98%-15.62M-7.35%-62.02M18.11%-12.9M7.86%-14.55M
Net income continuous Operations -87.47%-16.85M48.24%-8.08M39.47%-37.54M63.16%-4.75M43.75%-8.19M49.46%-8.99M6.98%-15.62M-7.35%-62.02M18.11%-12.9M7.86%-14.55M
Minority interest income
Net income attributable to the parent company -87.47%-16.85M48.24%-8.08M39.47%-37.54M63.16%-4.75M43.75%-8.19M49.46%-8.99M6.98%-15.62M-7.35%-62.02M18.11%-12.9M7.86%-14.55M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -87.47%-16.85M48.24%-8.08M39.47%-37.54M63.16%-4.75M43.75%-8.19M49.46%-8.99M6.98%-15.62M-7.35%-62.02M18.11%-12.9M7.86%-14.55M
Basic earnings per share -86.67%-0.2848.15%-0.1439.62%-0.6463.64%-0.0844.00%-0.1450.00%-0.156.90%-0.270.93%-1.0618.52%-0.227.41%-0.25
Diluted earnings per share -86.67%-0.2848.15%-0.1439.62%-0.6463.64%-0.0844.00%-0.1450.00%-0.156.90%-0.270.93%-1.0618.52%-0.227.41%-0.25
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg
Concept Top Gainers Yesterday
Top Gainers Yesterday
Intraday-4.29%